Furthermore, we also show that Resveratrol-induced inactivation of AKT is also ROS release dependent as pre-treatment of DLBCL cells with N-acetyl cysteine (NAC), a scavenger of ROS inhibited Resveratrol-induced inactivation of AKT. This evidence concerns the gene AKT1 and diffuse large B-cell lymphoma.